Drug Trial Radar · NCT05770609
A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Aug 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
53
Actual
Start
Jun 19, 2023
Primary completion
Sep 13, 2024
Study completion Sep 13, 2024
Sponsor
- Lead sponsor
- Shanghai Pharmaceuticals Holding Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Mar 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To preliminarily evaluate the clinical efficacy of the renin inhibitor SPH3127 Tablets in patients with mild to moderate ulcerative colitis with placebo as a control and determine the recommended dose.
Conditions
- Mild to Moderate Ulcerative Colitis
Interventions
SPH3127 Tablets with Dose ADrug
See Arm description
SPH3127 Tablets with Dose BDrug
See Arm description
SPH3127 Tablets placeboDrug
See Arm description
Primary outcomes
What the sponsor says the trial is designed to measure.
- Symptom remission rateTime frame: Week8
- Endoscopic remission rateTime frame: Week8
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Beijing Chao-Yang Hospital,Capital Medical University
Beijing, China
Peking University Third Hospital
Beijing, China
Chifeng Municipal Hospital
Chifeng, China
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Shanghai Jiaotong University School of Medicine, Renji Hospital
Shanghai, China
Tianjin Medical University General Hospital;
Tianjin, China
The First Affiliated Hospital,Sun Yat-sen University
Guangzhou, Guangdong, China
The Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Huizhou First Hospital
Huizhou, Guangdong, China
Nanfang Hospital, Southern Medical University
Guangzhou, Guanmgdong, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, He'nan, China
Affiliated Hospital of Hebei University
Baoding, Hebei, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The First Affiliated Hospital of Henan University
Kaifeng, Henan, China
Union Hospital Tongji Medical College Huazhong Universitu of Science and Technology
Wuhan, Hubei, China
Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
The First Hospital of Hunan University of Chinese Medicine
Changsha, Hunan, China
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Shengjing Hospital affiliated to China Medical University
Shenyang, Liaoning, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
Xi'an Central Hospital
Xi’an, Shanxi, China
Suining Central Hospital
Suining, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.